Cardiovascular Risk in HIV Patients Switching From a Boosted Protease Inhibitor (PI) to Dolutegravir (DTG)
Clinical trial NCT02098837 · COMPLETED
Trial details
- NCT number
- NCT02098837
- Sponsor
- St Stephens Aids Trust
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-11-01
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.